Drugs, Devices, and Diagnostics
Latest | Media coverage | Commentary | Academic Literature | Legislation | Reports and Government Documents
Covering prescription medicines and medical devices, which includes instruments, implants, scans and tests, as well as screening and health promoting interventions.
Latest
Media coverage
Natural Health manufacturers frustrated at lack of progress on regulation
The body representing New Zealand natural product manufacturers says the lack of modern regulation for the sector means New Zealand companies continue to struggle to compete on the world stage.
Prescription for change: New Medical Products Bill expected
The Government has recently announced its plan to modernise the regulation of medicines and medical devices by replacing the Medicines Act 1981 with a new Medical Products Bill (Bill). It has also decided that natural health products would be regulated under a standalone bill, yet to be developed.
Puberty blocker use in New Zealand far higher than similar countries – study
New Zealand is prescribing up to seven times more puberty blockers to young transgender patients than other similar countries, new analysis shows.
Commentary
Saving our med labs before they end up on the slab
Ian Powell formed his ideas of pathologists from watching too many crime dramas involving forensic pathologists. His favourite was CSI's Doc Robbins.
NZ already spends less on health than Australia or Canada – we need proper funding, not ‘crisis’ management
We are being told the health system is in crisis, “on the brink of failure” – spending beyond its budget, waiting times getting longer, suffering from widespread staff shortages. Read...
How the Treaty really guides NZ’s drug-buying policies
Associate health minister David Seymour’s directive to Pharmac may streamline decisionmaking but it downplays the true role of the Treaty of Waitangi, writes Dominic O’Sullivan
Academic Literature
Accessing diagnosis and treatment: The experience of cancer as wrangling with the system
Dew et al. We argue that for most people with long-term cancer survival wrangling is a social practice, but the capacity to succeed in that practice is dependent on a range of factors, including levels of economic, cultural, and social capital. Read...
The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand
Consistent with existing literature, we find that the level of frailty is significantly associated with the cost of healthcare. However, we find no association between drug burden and nonpharmaceutical/overall healthcare costs.
A realist evaluation of the development of extended pharmacist roles and services in community pharmacies
Four intermediate health service outcomes were identified: development of extended community pharmacist services; consumers using extended community pharmacist services; more integrated, collaborative primary health care services; and a fit-for-purpose community pharmacy workforce.
Legislation and Parliament
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Reports and Government Documents
New year, new medicines
Associate Health Minister with responsibility for Pharmac David Seymour is pleased to see Pharmac continue to increase availability of medicines for Kiwis with the government’s largest ever investment in Pharmac.
Consultation to increase ADHD medicine access begins
The proposal suggests broadening the range of people who can initiate treatment of stimulant medicines which, over time, would lead to more doctors and nurse practitioners being able to diagnose and treat ADHD.
Gene technology regulation
Gene technology (also known as genetic engineering or genetic modification) has been used in New Zealand for a long time. The updated rules intend to support our scientists in using gene technologies to make advancements in healthcare and climate change, protect our unique environment, lift our agricultural productivity, and boost exports.
Key issues
HEALTH SERVICES AND SYSTEMS
EQUITY
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI